KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Sales (2016 - 2025)

Historic Return on Sales for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 0.28%.

  • Dynavax Technologies' Return on Sales rose 700.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 0.1% for FY2024, which is 1300.0% up from last year.
  • As of Q3 2025, Dynavax Technologies' Return on Sales stood at 0.28%, which was up 700.0% from 0.2% recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Return on Sales peaked at 0.51% during Q4 2021, and registered a low of 1.41% during Q1 2025.
  • Its 5-year average for Return on Sales is 0.07%, with a median of 0.2% in 2025.
  • Per our database at Business Quant, Dynavax Technologies' Return on Sales skyrocketed by 104800bps in 2021 and then crashed by -12400bps in 2025.
  • Over the past 5 years, Dynavax Technologies' Return on Sales (Quarter) stood at 0.51% in 2021, then decreased by -28bps to 0.37% in 2022, then plummeted by -99bps to 0.0% in 2023, then surged by 2385bps to 0.1% in 2024, then soared by 190bps to 0.28% in 2025.
  • Its Return on Sales stands at 0.28% for Q3 2025, versus 0.2% for Q2 2025 and 1.41% for Q1 2025.